Abstract
Most human tumors are clonal in origin, although the cells may be diverse in their properties. Since the tumors evolve through progressive stages over decades of time, it is possible that the conditions that induced the tumor transform many cells, but that selective overgrowth of the fastest growing lead to a clonal population of identified tumor cells. We studied the progression of neoplastic transformation in clones from a population in which about 10% of the cells formed well-defined transformed foci. A few of the clones produced many large foci, but most of the clones produced no foci or only one focus. Maintenance of the nonproducing and low-producing clones under the growth constraint of confluence and low serum concentration, which promotes transformation, led to the production of large numbers of small foci by all of them. Visual inspection revealed considerable heterogeneity in size and density among the foci from each clone, and this was quantitated by computer scanning. Subclonal analysis of focus formation was done on one of the clones after it had undergone further growth constraint to promote transformation. As in the original cloning, some of the subclones produced many large foci, but most produced none. Another round of growth constraint was imposed on the nonproducing subclones, which then became producers of many small foci varying in size and density. The results indicate that most if not all cells in the population respond to growth constraint by undergoing transformation. Though there is wide variation in the degree of transformation, the results are consistent with the view that an entire field of cells exposed to carcinogenic conditions in an animal undergoes some progression toward neoplasia but that heterogeneity of the response followed by selective neoplastic growth may lead to a clonal origin of the clinically detected tumor.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett J. C., Crawford B. D., Grady D. L., Hester L. D., Jones P. A., Benedict W. F., Ts'o P. O. Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. Cancer Res. 1977 Oct;37(10):3815–3823. [PubMed] [Google Scholar]
- Camps J. L., Chang S. M., Hsu T. C., Freeman M. R., Hong S. J., Zhau H. E., von Eschenbach A. C., Chung L. W. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A. 1990 Jan;87(1):75–79. doi: 10.1073/pnas.87.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cullen K. J., Smith H. S., Hill S., Rosen N., Lippman M. E. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res. 1991 Sep 15;51(18):4978–4985. [PubMed] [Google Scholar]
- Farber E., Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res. 1991 Jun 1;51(11):2751–2761. [PubMed] [Google Scholar]
- Fialkow P. J. Clonal origin of human tumors. Annu Rev Med. 1979;30:135–143. doi: 10.1146/annurev.me.30.020179.001031. [DOI] [PubMed] [Google Scholar]
- Fox M., Radacic M. Adaptational origin of some purine-analogue resistant phenotypes in cultured mammalian cells. Mutat Res. 1978 Feb;49(2):275–296. doi: 10.1016/0027-5107(78)90166-5. [DOI] [PubMed] [Google Scholar]
- Harris M., Collier K. Phenotypic evolution of cells resistant to bromodeoxyuridine. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4206–4210. doi: 10.1073/pnas.77.7.4206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jainchill J. L., Todaro G. J. Stimulation of cell growth in vitro by serum with and without growth factor. Relation to contact inhibition and viral transformation. Exp Cell Res. 1970 Jan;59(1):137–146. doi: 10.1016/0014-4827(70)90632-4. [DOI] [PubMed] [Google Scholar]
- Kraemer P. M., Travis G. L., Ray F. A., Cram L. S. Spontaneous neoplastic evolution of Chinese hamster cells in culture: multistep progression of phenotype. Cancer Res. 1983 Oct;43(10):4822–4827. [PubMed] [Google Scholar]
- Mackie E. J., Chiquet-Ehrismann R., Pearson C. A., Inaguma Y., Taya K., Kawarada Y., Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4621–4625. doi: 10.1073/pnas.84.13.4621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noble R. L. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 1977 Jan;37(1):82–94. [PubMed] [Google Scholar]
- Rubin A. L., Arnstein P., Rubin H. Physiological induction and reversal of focus formation and tumorigenicity in NIH 3T3 cells. Proc Natl Acad Sci U S A. 1990 Dec;87(24):10005–10009. doi: 10.1073/pnas.87.24.10005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin A. L., Ellison B. J. Induction of transformation in NIH3T3 cells by moderate growth constraint: evidence that neoplasia is driven by adaptational change. Carcinogenesis. 1991 Oct;12(10):1801–1806. doi: 10.1093/carcin/12.10.1801. [DOI] [PubMed] [Google Scholar]
- Rubin A. L., Yao A., Rubin H. Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity. Proc Natl Acad Sci U S A. 1990 Jan;87(1):482–486. doi: 10.1073/pnas.87.1.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin H. Adaptive evolution of degrees and kinds of neoplastic transformation in cell culture. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):977–981. doi: 10.1073/pnas.89.3.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin H., Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1860–1864. doi: 10.1073/pnas.86.6.1860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shipley G. D., Ham R. G. Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro. 1981 Aug;17(8):656–670. doi: 10.1007/BF02628401. [DOI] [PubMed] [Google Scholar]